Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
Neovascular age-related macular degeneration (nAMD) leads to visual impairment if not treated promptly. Intravitreal anti-VEGF drugs have revolutionized nAMD treatment in the past two decades. We evaluated the visual outcomes of anti-VEGF treatment in nAMD. A real-life population-based cohort study....
Saved in:
Main Authors: | Ida Korva-Gurung (Author), Anna-Maria Kubin (Author), Pasi Ohtonen (Author), Nina Hautala (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study
by: Anna-Maria Kubin, et al.
Published: (2024) -
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
by: Kaiser SM, et al.
Published: (2021) -
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
by: Yang S, et al.
Published: (2016) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023) -
Comparison of morphometric changes in the chorioretinal complex after anti-VEGF treatment in patients with pathologic myopia versus those with neovascular age-related macular degeneration
by: O.M. Blavatska, et al.
Published: (2018)